The COVID-19 and Cancer Consortium: A Crowdsourced Research Platform
This event is part of the DCI Network Webinars on COVID-19 Data Platforms and Telemedicine event series.
view the recording and slides.
Jeremy L. Warner MD, MS, FAMIA, FASCO (he/him/his)
Associate Professor (appointment pending) of Medicine and Public Health at Brown University
Adjunct Associate Professor of Medicine at Vanderbilt University
Director, Brown/Lifespan Center for Cancer Bioinformatics and Data Science (CCBiDS)
Director, COVID-19 and Cancer Consortium (CCC19) Research Coordinating Center
Deputy Editor, JCO Clinical Cancer Informatics
Deputy Editor, HemOnc.org
Cancer is the second-leading cause of death in the United States. In addition, cancer is one of the most frequently diagnosed serious illnesses, with an estimated 16.9 million Americans with a history of an invasive malignancy alive as of January 1, 2019. Nearly 2 million invasive cancer cases were expected to be diagnosed in 2020. At the beginning of the COVID-19 pandemic, Advocate Aurora Health, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, the University of Miami, and Vanderbilt University Medical Center (VUMC) led the formation of the COVID-19 and Cancer Consortium (CCC19), to rapidly collect and disseminate information about the especially vulnerable population of patients with active cancer and cancer survivors who are diagnosed with COVID-19. CCC19 started accruing data on March 17, 2020. As of September 2022, 123 institutions across North America have joined the consortium, with more than 15,000 cases reported to date. CCC19 maintains a registry to collect granular data about baseline characteristics, initial course of COVID-19, and longer-term outcomes.
Jeremy L. Warner MD, MS, FAMIA, FASCO is an Associate Professor of Medicine and Public Health at Brown University (appointment pending); he is an attending physician at the Lifespan Cancer Institute. He is board certified in Medical Oncology, Hematology, and Clinical Informatics; his clinical focus is malignant hematology. Dr. Warner is the deputy editor of JCO Clinical Cancer Informatics and section co-editor of Cancer Informatics for the IMIA Yearbook. His primary research goal is to make sense of the structured and unstructured data present in electronic health records (EHRs) and clinical knowledge bases. He is the deputy editor of HemOnc.org, and chief software architect of HemOnc, an ontology focused on capturing all relevant knowledge pertinent to chemotherapy drugs and regimens. In June 2022, he transitioned to Brown University, where he is launching the Center for Cancer Bioinformatics and Data Science (CCBiDS).
Learn more at: https://www.lifespan.org/providers/jeremy-lyle-warner-md-ms-famia-fasco